Stockscreener 앱 받기
29.07
3.16%
-0.95
시간 외 거래:
29.07
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure targets $517M-$527M revenue in 2025 with strong growth in appendage management and pain management - MSN
Left Atrial Appendage Closure Market to Set Phenomenal Growth - openPR.com
AtriCure, Inc. (NASDAQ:ATRC) Q1 2025 Earnings Call Transcript - Insider Monkey
Shareholders in AtriCure (NASDAQ:ATRC) have lost 40%, as stock drops 11% this past week - Yahoo Finance
AtriCure, Inc. (NASDAQ:ATRC) Screens Well But There Might Be A Catch - simplywall.st
Needham cuts AtriCure stock target to $44, maintains buy rating By Investing.com - Investing.com Nigeria
AtriCure price target lowered to $52 from $58 at BTIG - TipRanks
AtriCure price target lowered to $51 from $52 at Canaccord - TipRanks
AtriCure’s Strong Q1: Revenue Growth and Challenges - TipRanks
Needham cuts AtriCure stock target to $44, maintains buy rating - Investing.com Australia
UBS Adjusts AtriCure (ATRC) Price Target Amid Core Business Stre - GuruFocus
AtriCure, Inc. SEC 10-Q Report - TradingView
UBS Adjusts Price Target on AtriCure to $58 From $60, Maintains Buy Rating - marketscreener.com
14 Analysts Assess AtriCure: What You Need To Know - Benzinga
AtriCure (ATRC) Target Price Revised Amid Mixed Sector Performan - GuruFocus
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
AtriCure (ATRC) Buy Rating Reaffirmed Despite Adjusted Price Tar - GuruFocus
JMP maintains AtriCure stock $60 target post 1Q25 results - Investing.com
JMP maintains AtriCure stock $60 target post 1Q25 results By Investing.com - Investing.com India
AtriCure Inc (ATRC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
(ATRC) Investment Report - news.stocktradersdaily.com
AtriCure, Inc. Reports Strong Q1 2025 Growth - TipRanks
AtriCure Inc (ATRC) Q1 2025 Earnings: EPS of -$0.14 Beats Estima - GuruFocus
Earnings call transcript: AtriCure Q1 2025 beats EPS expectations, stock up 2.9% - Investing.com Nigeria
AtriCure: Q1 Earnings Snapshot - Midland Daily News
ATRC Revenue Forecast for 2025 and Earnings Outlook | ATRC Stock News - GuruFocus
AtriCure (ATRC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
AtriCure Reports First Quarter 2025 Financial Results - BioSpace
AtriCure (ATRC) Exceeds Q1 Revenue Expectations with Strong Prod - GuruFocus
ATRICURE Earnings Results: $ATRC Reports Quarterly Earnings - Nasdaq
Earnings Flash (ATRC) ATRICURE INC. Posts Q1 Revenue $123.6M, vs. FactSet Est of $122.9M - marketscreener.com
Medical Device Giant AtriCure Posts Double-Digit Growth: Q1 Revenue Hits $124M as Margins Expand - Stock Titan
AtriCure Earnings Preview - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
Left Appendage Occlusion Device Market Top Companies Study - openPR.com
Cryoablation Market Set to Witness Significant Growth by 2032 | - openPR.com
AtriCure Announces First Use of the AtriClip PRO-Mini® Device | ATRC Stock News - GuruFocus
AtriCure Announces First Use of the AtriClip PRO-Mini® Device | - GuruFocus
AtriCure launches smaller device for heart surgery By Investing.com - Investing.com South Africa
AtriCure announces first use of newest AtriClip device - MassDevice
AtriCure Reports 1st Use of Newest AtriClip LAA Exclusion System - Medical Product Outsourcing
AtriCure launches smaller device for heart surgery - Investing.com Australia
AtriCure Announces First Use of the AtriClip PRO-Mini® Device - Yahoo Finance
Dayton’s stocks continue loss streak following election and now tariffs - The Business Journals
AtriCure Drops 25%: Bargain Or Caution Sign? (NASDAQ:ATRC) - Seeking Alpha
AtriCure to Announce First Quarter 2025 Financial Results - MarketScreener
Is AtriCure (NASDAQ:ATRC) A Risky Investment? - simplywall.st
1.08%
자본화:
|
볼륨(24시간):